QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 28, 2004, 24(30):6799-6809; doi:10.1523/JNEUROSCI.5463-03.2004

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (50) Citing Articles via Google Scholar Google Scholar Articles by Tong, L. Articles by Cotman, C. W. Search for Related Content PubMed PubMed Citation Articles by Tong, L. Articles by Cotman, C. W.

 Previous Article  |  Next Article 

Cellular/Molecular
-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons

Liqi Tong, Robert Balazs, Phillip L. Thornton, and Carl W. Cotman

Institute for Brain Aging and Dementia, University of California Irvine, Irvine, California 92697-4540

The accumulation of -amyloid (A) is one of the etiological factors in Alzheimer's disease (AD). It has been assumed that the underlying mechanism involves a critical role of A-induced neurodegeneration. However, low levels of A, such as will accumulate during the course of the disease, may interfere with neuronal function via mechanisms other than those involving neurodegeneration. We have been testing, therefore, the hypothesis that A at levels insufficient to cause degeneration (sublethal) may interfere with critical signal transduction processes. In cultured cortical neurons A at sublethal concentrations interferes with the brain-derived neurotrophic factor (BDNF)-induced activation of the Ras-mitogen-activated protein kinase/extracellular signal-regulated protein kinase (ERK) and phosphatidylinositol 3-kinase (PI3-K)/Akt pathways. The effect of sublethal A_1-42 on BDNF signaling results in the suppression of the activation of critical transcription factor cAMP response element-binding protein and Elk-1 and cAMP response element-mediated and serum response element-mediated transcription. The site of interference with the Ras/ERK and PI3-K/Akt signaling is downstream of the TrkB receptor and involves docking proteins insulin receptor substrate-1 and Shc, which convey receptor activation to the downstream effectors. The functional consequences of A interference with signaling are robust, causing increased vulnerability of neurons, abrogating BDNF protection against DNA damage- and trophic deprivation-induced apoptosis. These new findings suggest that A engenders a dysfunctional encoding state in neurons and may initiate and/or contribute to cognitive deficit at an early stage of AD before or along with neuronal degeneration.

Key words: -amyloid; BDNF; CREB; MAPK; cortical neurons; PI3-K

---

Received Dec 12, 2003; revised April 9, 2004; accepted April 30, 2004.

This article has been cited by other articles:

				S. Peng, D. J. Garzon, M. Marchese, W. Klein, S. D. Ginsberg, B. M. Francis, H. T. J. Mount, E. J. Mufson, A. Salehi, and M. Fahnestock Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease J. Neurosci., July 22, 2009; 29(29): 9321 - 9329. [Abstract] [Full Text] [PDF]

				H.-K. Lee, P. Kumar, Q. Fu, K. M. Rosen, and H. W. Querfurth The Insulin/Akt Signaling Pathway Is Targeted by Intracellular {beta}-Amyloid Mol. Biol. Cell, March 1, 2009; 20(5): 1533 - 1544. [Abstract] [Full Text] [PDF]

				J. Gunstad, A. Benitez, J. Smith, E. Glickman, M. B. Spitznagel, T. Alexander, J. Juvancic-Heltzel, and L. Murray Serum Brain-Derived Neurotrophic Factor Is Associated With Cognitive Function in Healthy Older Adults J Geriatr Psychiatry Neurol, September 1, 2008; 21(3): 166 - 170. [Abstract] [PDF]

				E. Sturchler, A. Galichet, M. Weibel, E. Leclerc, and C. W. Heizmann Site-Specific Blockade of RAGE-Vd Prevents Amyloid-{beta} Oligomer Neurotoxicity J. Neurosci., May 14, 2008; 28(20): 5149 - 5158. [Abstract] [Full Text] [PDF]

				S. Petratos, Q.-X. Li, A. J. George, X. Hou, M. L. Kerr, S. E. Unabia, I. Hatzinisiriou, D. Maksel, M.-I. Aguilar, and D. H. Small The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism Brain, January 1, 2008; 131(1): 90 - 108. [Abstract] [Full Text] [PDF]

				D. J. Garzon and M. Fahnestock Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells J. Neurosci., March 7, 2007; 27(10): 2628 - 2635. [Abstract] [Full Text] [PDF]

				N. Chow, R. D. Bell, R. Deane, J. W. Streb, J. Chen, A. Brooks, W. Van Nostrand, J. M. Miano, and B. V. Zlokovic Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype PNAS, January 16, 2007; 104(3): 823 - 828. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help